...
首页> 外文期刊>PM & R: the journal of injury, function, and rehabilitation >Therapeutic Synergism in the Treatment of Post-stroke Arm Paresis Utilizing Botulinum Toxin, Robotic Therapy, and Constraint-induced Movement Therapy
【24h】

Therapeutic Synergism in the Treatment of Post-stroke Arm Paresis Utilizing Botulinum Toxin, Robotic Therapy, and Constraint-induced Movement Therapy

机译:利用肉毒杆菌毒素,机器人疗法和约束性运动疗法治疗卒中后手臂麻痹的治疗协同作用

获取原文
获取原文并翻译 | 示例

摘要

Botulinum toxin type A (BtxA) injection, constraint-induced movement therapy (CIMT), and robotic therapy (RT) each represent promising approaches to enhance arm motor recovery after stroke. To provide more effective treatment for a 50-year-old man with severe left spastic hemiparesis, we attempted to facilitate CIMT with adaptive approaches to extend the wrist and fingers using RT for 10 consecutive weeks after BtxA injection. This combined treatment resulted in substantial improvements in arm function and the amount of arm use in activities of daily living, and may be effective for stroke patients with severe arm paresis. However, we were unable to sufficiently prove the efficacy of combined treatment based only on a single case. To fully elucidate the efficacy of the combined approach for patients with severe hemiparesis after stroke, future studies of a larger number of patients are needed.
机译:A型肉毒杆菌毒素(BtxA)注射,约束诱导运动疗法(CIMT)和机器人疗法(RT)均代表增强中风后手臂运动恢复的有前途的方法。为了为50岁的严重左痉挛性偏瘫患者提供更有效的治疗,我们尝试通过BtxA注射后连续10周采用适应性方法促进CIMT,采用适应性方法通过RT延长手腕和手指。这种综合治疗使手臂功能和日常生活活动中的手臂使用量大大提高,并且可能对患有严重手臂轻瘫的中风患者有效。但是,我们无法仅基于单个病例就充分证明联合治疗的有效性。为了充分阐明联合治疗对中风后严重偏瘫患者的疗效,需要对大量患者进行进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号